| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |